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Abstract
Objectives: Studies have shown that human and peripheral blood mononuclear cells (PBMCs)
are mostly used for research purposes to study several biochemical endpoints. The effects of the
flavonoids, genistein, kaempferol, and quercetin on phospho tensin homolog (PTEN) levels in
cancer cells (i.e., breast [BT549], lung [A549]), human embryonic kidney cells (HEK293), and the
levels of lipid peroxides (LP) in PBMCs were respectively investigated.
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Materials and methods: Cancer, kidney, and PBMCs from several donors were each exposed
to each of the flavonoids at concentrations of 0, 5, 10, 15, 20, and 25 μM. Our hypotheses were
that exposure of cancer and kidney cells to genistein, kaempferol, and quercetin can increase
PTEN and decrease lipid peroxides in PBMCs levels respectively to better cope with oxidative
stress.
Results: The results indicate that the flavonoids increased total PTEN levels in a dose-dependent
manner. The effect of quercetin was more pronounced followed by genistein and kaempferol.
Furthermore, decreases in lipid peroxides were observed in the PBMCs for the flavonoid-treated
samples compared to those exposed to flavonoids and with oxidative stress as described by
Fenton’s chemistry. Levels of LP in quercetin-treated samples were lower compared to kaempferol
and genistein.
Conclusions: The findings suggest that the flavonoids play an important role in controlling
oxidative stress in several human cells.
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Introduction
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Phosphatase and tensin homolog (PTEN) was discovered in 1997 independently by three
laboratories as a tumor suppressor of which the expression is often lost in tumors (1–3).
Later studies established that PTEN is a negative regulator of a major cell growth and
survival signaling pathway, namely the phosphatidylinositol-3-kinase (PI3K)/Akt signaling
pathway (1, 2). The biological effects of PTEN, however, are dominated by its ability to
dephosphorylate the lipid substrate phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P3)
whereas protein substrates for PTEN are being discovered (4). PI-3,4,5-P3 is formed when
PI3K is stimulated as a result of growth factors binding to their receptors that are coupled to
PI3K (3). The enzymatic function of PTEN thus reduces the cellular concentration of
PI-3,4,5-P3 and acts as a negative regulatory signaling for the PI3K mitogenic signaling
pathway (3). Accumulation of PI-3,4,5-P3 serves as a major signal for growth factor
accumulation where PI-3,4,5-P3 binds to the pleckstrin homology (PH) domain of
downstream proteins (e.g., Akt) and provides a lipid moiety for these proteins to bind to the
lipid membranes (4). Binding of PI-3,4,5-P3 to the PH domain also changes the confirmation
of these proteins so they can later be activated by phosphorylation. By reducing the
intracellular levels of PI-3,4,5-P3, PTEN inhibits the activation of downstream proteins of
the PI3K pathway, including the serine/threonine kinase Akt and the protein kinase C (3). It
has also been reported that activation of hPPARγ causes an increase in PTEN protein levels
or a decrease in transforming growth factor β1 levels, resulting in tumor suppression through
induction of apoptosis, inhibition of cellular growth, and/or promotion of cellular
differentiation of cancer cells (5–7).
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Peripheral blood mononuclear cells (PBMCs) generally refer to monocytes and
lymphocytes, representing cells of the innate and adaptive immune systems. PBMCs are a
promising target tissue in the field of nutrigenomics because they seem to reflect the effects
of dietary modifications at the level of gene expression (8). Current studies have
demonstrated that PBMCs seem to reflect liver environment and complement adipose tissue
findings in transcriptomics (8). The main function of the immune system is to prevent or
limit infections by microorganisms such as bacteria, viruses, fungi, and parasites. Immune
responses are mediated by lymphocytes (white blood cells [WBCs], which derive from
precursors in the bone marrow and then migrate to guard peripheral tissues (9). For example,
WBCs are cells of the adaptive immune system, which recognize specific pathogens and act
by protecting against recurrent infections and are the largest cell population covered by the
more general term PBMCs, which also include monocytes (9). PBMCs seem to reflect
hepatic regulation of cholesterol metabolism (10) and can migrate through the blood
circulation and infiltrate various tissues such as the endothelium and adipose tissue (11).
Since PBMCs can also reflect the responses of dietary modifications and drugs at the level
of gene expression (12, 13), they have also been a subject of great interest in clinical and
intervention studies for transcriptomics profiling (8). Furthermore, PBMCs are convenient
because they can be easily and repeatedly collected in sufficient quantities, in contrast to
adipose, muscle, and liver tissues. However, PBMC transcriptomics from dietary
intervention studies have not resulted yet in clear confirmation of candidate genes related to
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disease risk. Use of microarray technology in larger well-designed dietary intervention
studies are still needed for exploring PBMCs’ potential in the field of nutrigenomics (8).
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In our recent studies on the effects of quercetin, kaempferol, and exogenous glutathione on
phospho- and total-Akt in 3T3-L1 preadipocytes we observed significant decreases in
phospho-Akt levels in cells treated each with either quercetin, kaempferol, or reduced
Glutathione (GSH) at several doses compared to their respective controls (14). As described
in the above studies (14), 3T3-L1 preadipocytes, exposed to quercetin, kaempferol, and GSH
respectively blocked the activation of Akt, suggesting the importance of quercetin,
kaempferol and GSH in preadipocytes cell differentiation (14). In view of those findings, it
became obvious and plausible to hypothesize that the decreases in Akt following exposure to
the flavonoids may indicate a direct increase on the expression levels of PTEN in cells.
Furthermore, PBMC gene expression after dietary intervention studies can be used for
studying the response of certain genes related to fatty acid and cholesterol metabolism and
to explore the response of dietary interventions in relation to inflammation. Thus, the
purpose of the present study was to further investigate the effects of exposure of several
doses each of genistein, kaempferol, and quercetin (i.e., 0, 5, 10, 15, 20, and 25 μM doses)
on the levels of PTEN in two cancer cell lines, namely, breast (BT549) and lung (A549) and
human embryonic kidney cells (HEK293). Second, we sought to study the effects of the
flavonoids on lipid peroxides in PBMCs before and following exposure to oxidative stress
through the Fenton’s chemistry. Our study will test two hypotheses: (1) Exposure of cancer
cells to either genistein, kaempferol, or quercetin can increase PTEN levels in those cells
and to better cope with oxidative stress. (2) The flavonoids might help individuals better
cope with oxidative damage through the inflammatory processes by PBMCs cells by
decreasing the levels of lipid peroxides. The proposed studies represent an effort to define
how genistein, kaempferol, and quercetin modulate the expression levels of PTEN, a tumor
suppressor gene, in lung, breast, and kidney cells as wells the levels of oxidation in PBMC
cells following exposure. In terms of future directions, we will follow the lead set by the
experimental results.
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Materials and methods
Chemicals
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Isoflavone kaempferol (3,5,7-trihydroxy-2-(4-hydroxy-phenyl)-4H-chromen-4-one) and
genistein (4′,5,7-trihydroxy isoflavone) and quercetin dihydrate (3,3′,4′,5,7Pentahydroxyflavone dihydrate) were from Sigma-Aldrich (St. Louis, MO). Disodium
Ethylenediaminetetraacetic acid (EDTA), ferrous sulfate (FeSO4), Dulbecco’s Modified
Eagle’s Medium (DMEM), Roswell Park Memorial Institute (RPMI) media, and hydrogen
peroxide(H2O2), were purchased from Fisher Scientific Suwanee, GA. Lung (A549), breast
(BT549), and kidney (HEK293) cancer cell lines were obtained from the American Type
Culture Collection, Manassas, VA. Blood filters were generously donated by the American
Red Cross of Nashville, TN. All chemicals were of high purity (>99%), according to the
manufacturer, and were used without further purification.
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Preparation of PBMCs
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peripheral blood mononuclear cells’ (PBMCs), were isolated from leukocyte filters (Pall
corporation, Westborough, MA-Reduced red blood cells platelets leukocytes [RCPL])
obtained from the Red Cross Blood Bank Facility (Nashville, TN) as described in (15) with
some modifications. Leukocytes were retrieved from the filters by back-flushing them with
an elution medium (sterile phosphate buffered saline [PBS] pH 7.4 containing 5 mM
disodium EDTA and 2.5% [w/v] sucrose) and collecting the eluent. The eluent was layered
onto Ficoll-Hypaque (1.077 g/mL) and centrifuged at 1200 g for 30–50 minutes.
Granulocytes and red cells pelleted at the bottom of the tube while the PBMCs floated on
the Ficoll-Hypaque. Mononuclear cells were collected and washed with PBS (500 × g, 10
minutes). Following washing, the cells were layered on bovine calf serum for platelet
removal. The cells were then suspended in RPMI-1640 complete medium which consisted
of RPMI-1640 supplemented with 10% heat-inactivated bovine calf serum, 2 mM Lglutamine, and 50 U penicillin G with 50 μg streptomycin/ml. This preparation constituted
PBMCs.
Culturing of cancer, PBMC cells, and treatment with the flavonoids
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BT549, A549, HEK293, and PBMCs were maintained at 37 °C under 5% CO2 atmosphere
in DMEM containing 4 mM L-glutamine, 4500 mg/L glucose, 1 mM sodium pyruvate, 1500
mg/L sodium bicarbonate, 10% fetal bovine serum, and 1% penicillin and streptomycin5. At
80% confluence in T-75 flasks, the cancer cells were trypsinized with 3 ml of trypsin-EDTA
solution and later subcultured in six-well plates (at 5 × 105 cells/well) before treatments with
various flavonoids at the doses each of 0, 5, 10, 15, 20, and 25 μM. PBMC cells were also
seeded in six-well plates (at 1 × 106 cells/well) before treatments with the flavonoids. All the
cells following the treatments were cultured for 24 hours in the incubator under the same
conditions as described above.
Cell viability
Cell viability was assessed at the beginning and end of each exposure period. Viability was
determined using the trypan blue exclusion method. Cells were briefly mixed with trypan
blue and counted using a hemocytometer. The total number of cells and the total number of
live cells were determined for both control and treated cells to determine the percentage
viable cells.
Sample preparation following the treatments with flavonoids
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Cancer and human embryonic kidney cells were trypsinized with 1 ml trypsin-EDTA and
transferred into Eppendorf tubes. Wells were each washed with 330 μl DMEM media and
transferred into their respective tubes. PBMCs were also removed from the six well plates
and placed into Eppendorf tubes. The tubes were centrifuged in a refrigerated Eppendorf
table top centrifuge (Model # 5804 R, Suwanee, GA) at 4 °C for 10 minutes at 3000 RPM.
For PTEN analysis cells were lysed as described by the Ray Bio® Human/Mouse/Rat
Phospho-PTEN (S380) and Total PTEN ELISA Kit (Cat.#: PEL-PTEN-S380-T) with the
following modifications. Cells were rinsed with sterile PBS to remove any remaining
medium before adding the lysis buffer. They were then solubilized in 1X lysis buffer
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containing protease and phosphatase inhibitors. Cell lysates were pipetted up and down to
re-suspend and incubated with shaking at 8 °C for 30 minutes. Lysates were then centrifuged
at 13,000 RPM for 10 minutes 4 °C, and the supernatants were transferred into clean test
tubes and stored at −70 °C before use. For the analysis of lipid peroxides (measured as
malonaldehyde [MDA] levels) PBMCs were sonicated with 100 μL cold PBS on ice using
the Fisher Sonic Dismembrator (Model#: 100, Suwanee, GA) at a setting of 3 for 20 seconds
for each sample. Samples were centrifuged as described for the cell lysates and subsequently
stored at −70 °C before use.
Analysis of PTEN in cancer cell lines
PTEN levels in the cells after the treatments was analyzed as described by the RayBiotech
Human/Mouse/Rat Total PTEN ELISA Kit (Cat.#: PEL-PTEN-S380-T) with the following
modifications as described below.
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Preparation of positive control
Briefly, 400 μl of the 1x assay diluent was added to the vial containing the lyophilized
powder (HELACALS001-1 used as positive control) to prepare the serial dilutions. Care was
taken to make sure that the lyophilized powder was thoroughly dissolved in 400 μl of assay
diluent by gentle mix to prepare the Positive Control (P-1) to produce a dilution series as
indicated below. 300 μl of the 1x assay diluent was pipetted into several Eppendorf tubes
(i.e., P-2, P-3, and P4) and 150 μl from the P-1 solution and the rest of the P-tubes were
transferred in sequential order to produce a dilution series of P-1, P-2, P-3, and P-4. Care
was taken to bring all reagents and samples to room temperature (18–25 °C) before use.
Assay procedure
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100 μl of each sample or positive control (HELACALS001-1) were added to the appropriate
96-well plates and covered with the plate holder and incubated overnight at 4 °C with
shaking. Following the incubation, the solution in the wells was discarded and each well
washed four times with the 1 × wash solution. Care was taken to remove completely any
residual liquid to enhance a good performance of the assay by inverting the plate and
blotting against a clean paper towel. 100 μl of the prepared 1x detection antibody, anti-PTEN
(S380) or anti-PTEN, was added to the appropriate wells and incubated for 1 hour at room
temperature with shaking. The liquid in the wells was discarded after the incubation and the
wells were each washed three times with the wash buffer as described above.
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Further, 100 μl of the prepared 1× HRP-conjugated anti-rabbit IgG against anti-PTEN
(S380) or HRP-conjugated streptavidin were added to the corresponding wells and incubated
for 1 hour at room temperature with shaking. The solution in the wells was discarded and
washed three times with the wash buffer as previously described. After the incubation, 100
μl of the 3,3′,5,5′-tetramethylbenzidine one-step substrate reagent was added to each well
and incubated at room temperature in the dark with shaking for 30 minutes. Following the
incubation, 50 μl of the stop solution (i.e., 0.2 M sulfuric acid) [H2SO4]), was added to each
sample and the samples read in a Synergy 96 well plate reader (Winooski, VT) at 450 nm.
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Analysis of lipid peroxides in PBMCs
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MDA was analyzed as prescribed by the Calbiochem lipid peroxidation assay kit (Cat. No.
437634) with some modifications as described below. Cells were lysed by repetitive
freezing/thawing in sterile PBS. Then 650 μl of diluted 10.3 mM N-methyl-2-phenylindole,
in acetonitrile, was added to 200 μl of cell lysate and vortexed for three to four - seconds. To
assay for MDA only, 150 μl of the 12 N HCl solution instead of the methanesulfonic acid
was added to the samples, mixed and tightly closed. Samples were incubated at 45 °C for 60
minutes, cooled on ice and the absorbance measured at 586 nm in the plate reader as
described above under the assay procedure for PTEN. For controls, a blank sample was
prepared which contains all the reagents and the sterile PBS. Standard curves for MDA (as
bis[dimethyl acetal[ in 20 mM Tris-HCl buffer, pH 7.4) was prepared and used for
calculating the molar extinction coefficient (ε) of the measured product which was equal to
the slope of the line. The following equation was used to calculate the MDA levels in the
sample by the equation below:
[MDA] = (A − A0) × D/ε

Where: A is the absorbance at 586 nm for the sample A0 is the absorbance of the blank
D is the sample dilution factor (200 μl of a sample in a total volume of 1 ml)
ε is the apparent molar extinction coefficient obtained from the standard curve.
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Care was taken to ensure that those cloudy samples or samples containing cellular debris
were transferred to polypropylene micro tubes and centrifuged at 15,000 × g for 10 minutes
just prior to measuring the absorbance. The absorbance of the clear supernatant was read at
586 in a 96-well BioTek Synergi plate reader (Wilnooski, VT). MDA levels in cells were
corrected for protein and the results expressed as MDA/mg protein.
Statistical analysis
Results are expressed as means ± standard deviation. Statistical significance was determined
by two-way analysis of variance (ANOVA) followed by student’s t-test, and p < 0.05, was
considered statistically significant. Each value in all figures represents the mean for each
dose level of flavonoid and MDA tested, which was assayed in triplicates. PTEN values
were measured by absorbance level as stated in the manufacturer’s protocol.

Results
Author Manuscript

Effects of flavonoids on PTEN levels in cancer cell lines
Figures 1 through 3 show the effects of exposure of each of the respective flavonoids,
genistein, kaempferol, and quercetin, at 0, 5, 10, 15, 20, and 25 μM on PTEN levels in the
respective cells.
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Effects of the flavonoids on lung cancer cells (A549)
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As shown in Figure 1 for A549 cells, PTEN levels seem to increase for each of the
flavonoids in comparison to their respective controls. Genistein at 5, 15, and 20 μM showed
a significant increase (p < 0.05) in PTEN compared to its control. While PTEN levels in the
kaempferol-treated samples also increased significantly (p < 0.05) for each dose at 5 to 25
μM compared to its control, that of quercetin did not have an effect on PTEN but showed a
significant decrease (p < 0.05) only at the highest dose of 25 μM. Thus, with regard to
potency in altering PTEN levels, genistein showed the best effect in increasing PTEN levels
(Figure 1).
Effects of the flavonoids on breast cancer cells (BT549)
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As observed for the A549 cells (Figure 1) there was general increase in PTEN levels for
genistein and quercetin for the tested doses compared to their respective controls.
Kaempferol at 5 μM showed a significant decrease (p < 0.05) in PTEN and thereafter
remained the same for all the other doses compared to its control. At the 5- and 15-μM dose
levels, quercetin and genistein respectively showed significant (p < 0.05) increases in PTEN
levels compared to their respective controls. As observed for the lung cancer A549 cell lines
(Figure 1), kaempferol did not have any effect on PTEN levels except at the 15-μM dose
(Figure 2).
Effects of the flavonoids on human embryonic kidney cells (HEK293)
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Figure 3 shows the PTEN levels in HEK293 cells following exposure to the flavonoids at the
various doses tested. As observed for the BT459 cell lines (Figure 2), quercetin and
genistein at the respective doses of 5 and 15 μM showed significant (p < 0.05) increases in
PTEN levels compared to their respective controls. Again, and as observed for the A549 and
BT549 cell lines (Figures 1 and 2), kaempferol did not have any effect on PTEN levels at the
tested doses (Figure 3). With regard to A549 and BT549 cell (Figures 1 and 2) where
genistein and kaempferol had significant increases at the lower doses of 5 to 15 μM, the
opposite effect was observed for A549 at the highest doses of 20 and 25 μM.
Effect of the flavonoids on lipid peroxides in PBMCs in donors without and with oxidative
stress
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Effect of genistein on lipid peroxides in PBMCs without and with oxidative
stress—Figures 4 and 5 respectively show the effects of exposure of genistein on lipid
peroxides in PBMCs from three independent donors (F1, F2, and F3) without and with
oxidative stress. The results in Figure 4 indicate that lipid peroxides among the donors
varied differently and depended on the individual donor. Compared to each donor’s
respective control, there were no significant differences in lipid peroxides for the doses
tested except for donor F2, where a significant (p < 0.05) drop in lipid peroxides were
observed at the 25-μM dose. Lipid peroxides in PBMCs exposed to oxidative stress and the
flavonoids (Figure 5) compared to those exposed only to the flavonoids (Figure 4) increased
significantly (p < 0.05) for all the doses tested as analyzed by two-way ANOVA. Again,
lipid peroxides for the oxidative stressed PBMCs were not significantly different for each of
the donors compared to their respective controls (Figure 5).
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Effect of kaempferol on lipid peroxides in PBMCs without and with oxidative
stress—Figures 6 and 7 show the respective profiles of lipid peroxides in PBMCs for three
independent donors (F4, F5, and F6) treated with kaempferol only and with kaempferol in
the presence of oxidative stress. Lipid peroxides (Figure 6) increased significantly (p < 0.05)
for donor F5 at the 5- and 10-μM doses respectively compared to the control. At the 15-μM
dose for the same donor, however, lipid peroxide decreased significantly (p < 0.01)
compared respectively to its control and those of the 5- and 10-μM levels. Peroxide levels
(Figure 7) were significantly higher (p < 0.05) as previously observed for genistein (see
Figures 4 and 5) in comparison to PBMCs from donors exposed only to kaempferol (Figure
6). Increases in lipid peroxides were observed in PBMCs from donor F4 at the 15- and 25and F6 at the 5-, 20-, and 25-μM respective doses (Figure 7).

Author Manuscript
Author Manuscript

Effect of quercetin on lipid peroxides in PBMCs without and with oxidative
stress—The effects of quercetin on lipid peroxides in three independent donors (F7, F8,
and F9) following exposure to flavonoids only and in the presence of the flavonoid following
oxidative stress are shown in Figures 8 and 9, respectively. Again, as observed for genistein
and kaempferol, lipid peroxides were variable from donor to donor. Significant decreases (p
< 0.01) in lipid peroxides were observed for donor F7 at each of the doses from 10 to 25 μM
compared to its control (Figure 8). However, for donor F8, a significant increase in lipid
peroxide compared to its control was observed for the 20 and 25 μM, respectively. A
significant decrease (p < 0.05) in lipid peroxide was observed for donor F9 at 10 μM
compared to its control (Figure 8). Following exposure to quercetin and in the presence of
oxidative damage (Figure 9), lipid peroxides remained the same and not significantly
different for donors F7 and F8 for all the doses tested compared to their respective controls.
Surprisingly, significant increases (p < 0.05) in lipid peroxides for donor F8 was observed
for quercetin tested at each of the 10 to 25 μM levels and in the presence of oxidative stress.
Generally, lipid peroxides were lower for the quercetin-only treated samples (Figure 8)
compared to those both exposed to quercetin and in the presence of oxidative stress (Figure
9).

Discussion
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Flavonoids, a family of polyphenols, are generally found in various fruits and vegetables, as
well as in many plant beverages such as tea, pomegranate juice, raspberries, blueberries, and
red wine (16). Studies on flavonoids have attracted scientific attention as a potential
nutritional strategy to prevent a broad range of chronic disorders. For example, the
consumption of these flavonoids in sufficient amounts play neuroprotective,
cardioprotective, anti-inflammatory, and chemopreventive roles (16, 17). While there has
been a major focus on the antioxidant properties, there is an emerging view that flavonoids
and their in vivo metabolites do not act only as conventional antioxidants but may also exert
modulatory actions on cellular system through direct action on various signaling pathways
(18). These pathways include phosphoinositide 3-kinase, Akt/protein kinase B, mitogenactivated protein kinase, tyrosine kinases, and protein kinase C. The inhibitory or
stimulatory actions of flavonoids on these pathways greatly affect cellular functions by
altering the phosphorylation state of targeted molecules (18).
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In the present study, we further sought to investigate the effects of exposure of genistein,
kaempferol, and quercetin on the levels of PTEN in several human cells. In addition, we
investigated the effects of the above flavonoids on lipid peroxides in PBMCs before and
after exposure to oxidative stress as described by the Fenton’s chemistry (19). The primary
hypotheses were (1) that exposure of human cells to genistein, kaempferol, and quercetin
can increase PTEN levels in those cells to better cope with oxidative stress and (2) that the
flavonoids might help individuals better cope with oxidative damage by reducing the levels
of lipid peroxides in PBMCs. The proposed studies represent an effort to define how
genistein, kaempferol, and quercetin modulate the levels of PTEN, a tumor suppressor gene,
in breast and lung cancer and human embryonic kidney cells as well as the levels of
oxidation in PBMC from several donors.
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The results in the current studies indicate that genistein, quercetin and, to a lesser extent,
kaempferol seem to cause significant increases in the levels of PTEN in all the cancer and
the human embryonic kidney cells, suggesting the potency of such compounds in
modulating cell growth and probably enhancing cell programmed death. In fact, it has been
reported elsewhere that the soy phytoestrogens, genistein, daidzein, and equol, not only
controlled cell-cycle arrest and cell growth inhibition but induced apoptosis or programmed
cell death in prostate cancer cell apoptosis (20–23). We have previously observed decreases
in Akt levels in 3T3-L1 preadipocytes following exposure to genistein and quercetin and the
observed effects were attributed to the down-regulation of the Akt transcription factor (14)
or low expression of NF-κB (24–26). Thus, the increased PTEN levels attributed by
genistein and quercetin may be indirectly be due to decreased Akt levels in those cells as we
have previously reported (14). The differences between quercetin and genistein may indicate
that quercetin is able to directly curb the PI3K/Akt/IKKα/NF-κB in the cell lines leading to
the induction of cell apoptosis through a mitochondria-dependent mechanism. In fact, a
similar observation was seen in human salivary adenoid cystic carcinoma as previously
observed by Sun et al. (27) and as we have recently reported (14). Furthermore, many other
reports indicate that flavonoids, including quercetin, are inhibitors of different PI3K
isoforms and PI3K/Akt axis (28–30), making PI3K a possible molecular target for quercetin.
The fact is that quercetin is able to inhibit many other kinases and enzymes besides PI3K
and NF-κB-1, which makes it plausible to assume that the effectiveness also of quercetin in
comparison to genistein and kaempferol may be due to the multiple facets of quercetin
targeting several isoforms of the P13K isoforms. Third, the flavonol may act positively on
the kinase/suppressor factors, thus inducing indirect kinase inhibition. Furthermore,
quercetin is a strong DNA binder, as reported by Janjua et al. (31), and may be beneficial to
both individuals who are either genetically or not predisposed to cancer as a result of the
increases in the levels of PTEN. We have also shown, for the first time and among all the
tested flavonoids, that the effect of the various doses of kaempferol on the human cells on
the PTEN levels may be cell line-specific and could be due to the disruption of Tumor
necrosis factor (TNF)-mediated operations, as has been reported elsewhere (32) or the
ability of kaempferol to dramatically lower the production of reactive oxygen species in
HEK293 cells (32) and, ostensibly, significantly handicapping the TNF assembly in addition
to its broad spectrum of inflammatory effects. Our findings are in agreement in similar
studies where HEK 293 cells, when exposed to kaempferol, blocked not only TNF-induced
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Interleukin-8 (IL-8) promoter activation but also IL-8 gene expression, which has been
found to be a potent enhancer of angiogenesis as well, once again displaying the wide
variety of proteins kaempferol affects (33). In summary, increased PTEN levels following
flavonoid exposure may indicate low oxidative damage, as we have previously demonstrated
in 3T3-L1 preadipocytes and the cells investigated in the current studies.
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To demonstrate the effectiveness of the flavonoids on lipid peroxides before and during the
oxidative stress processes we have used PBMCs to characterize this phenomena. These cells
were selected because they seem to reflect hepatic regulation of cholesterol metabolism (10)
and can migrate through the blood circulation and infiltrate various tissues such as the
endothelium and adipose tissue (11). In addition, PBMC gene expression might reflect the
metabolic and immune responses of adipocytes or hepatocytes (11) as well as their
responses to dietary modifications and drugs at the level of gene expression (12, 13).
Furthermore, the cells are convenient to use because they can be easily and repeatedly
collected in sufficient quantities, in contrast to adipose, muscle, and liver tissues. We have
consistently observed decreases in lipid peroxides in PBMCs from donors exposed only to
the flavonoids and incubated for 24 hours. Such observations seem to suggest that increasing
the antioxidant potential of donor cells helps not only to reduce oxidation processes in those
individuals but may also help those cells better cope during inflammatory and/or oxidative
stress. Such findings seem to be in agreement with studies by other authors where
consumption of virgin olive oil (VOO) rich in phenolic compounds and high in
monounsaturated fatty acids seem to have healthy benefits in humans with disease risk
factors (34). Similarly, and in other studies, the authors explored the mechanisms of the
beneficial effects of VOO, a major component of a Mediterranean diet, on gene expression
at the mRNA levels in PBMCs (35). In that study, the addition of 25 ml per day of VOO upregulated not only genes involved in the DNA repairing system, antiapoptotic genes, but
those genes involved in antioxidant and oxidative cell defense mechanisms (34). Thus, it is
very plausible to suggest that a diet loaded with high antioxidant potential such as the
flavonoids could help reverse some potential damage(s) to cell function and viability. As to
why lipid peroxides increased in PBMCs exposed to the flavonoids and then subjected to
oxidative damage is very interesting. This is the very first observation of such a phenomenon
and could either mean that the levels of the flavonoids exposed to the PBMCs may not be
sufficiently adequate or there is a critical concentration needed by each donor to help those
individuals better cope with oxidative stress and cell damage. This phenomenon is contrary
to our previous studies, where we observed reduced lipid peroxides by flavonoids (36),
suggesting the need to further investigate the critical doses of the flavonoids that are needed
by the donors to offset any possible damage. Nevertheless, it is of interest to note that the
elucidation of the mechanisms of the flavonoid antioxidant capacity on health and how much
these benefits are related to reduce oxidative stress may depend on the donor. We also wish
to state that the use of PBMCs in the current study is not an intervention study in which
dietary manipulation was done by means of supplementation with the flavonoids since we
did not have all the relevant information on the donors with regard to background in terms of
dietary intake. The authors are suggesting that the above studies might be considered as a
proof of concept to demonstrate the beneficial effects of these flavonoids and their impacts
on the inflammatory process.
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The variability in the lipid peroxide data also seems to suggest that individual differences
both genetically and environmentally may dictate the critical levels of antioxidants for each
individual, family, or population (19) and/or may be due to our inability to access full
biographical data (due to confidentiality and compliance issues by the American Red Cross)
regarding their age, sex, lifestyle, and diet. The availability of such information could have
helped to normalize the data to their respective age, sex, and life-style for proper
interpretation of the data on the potency of the flavonoids. Nevertheless, and taken together,
our findings provide important insights into the mechanisms underlying the anti-obesity
activity of the flavonoids and may be mediated by the inhibition of Akt activation by the
decreased phosphorylation, which may induce the down-regulation of lipid accumulation
and lipid metabolizing genes as observed previously (14) and the concomitant increases in
PTEN as we have observed in the current study.
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Conclusions
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Our findings seem to suggest that the flavonoids are capable of enhancing the antioxidant
levels by increasing PTEN levels in several human cells to better cope with oxidative
damage. Second, individual differences in donor profiles may or may not truly reflect the
potential benefits of such compounds in one’s diet. However, the findings from the current
studies seem to suggest that consumption of foods containing polyphenols may help reduce
the causes of factors related to the metabolic syndrome (37–39) and those associated with
the anti-inflammatory mechanisms and improved antioxidant capacity (40, 41). Finally, the
increased activity of PTEN as we have observed in the current study could help explain the
concomitant low expression levels for both the phospho- and total-Akt gene (14), further
substantiating the inverse relationship between the expression levels of Akt and PTEN gene
as we and others have observed (14).
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Figure 1.
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The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and
quercetin on phospho tensin homolog (PTEN) in lung cancer cell line, A549, following
incubation at 37 °C and 5% CO2 for 24 h. Each bar chart for each flavonoid ± standard
deviation in this and Figures 2 and 3 in this article represent mean for three different
experiments for each dose level of genistein, kaempferol, and quercetin tested and which
was assayed in triplicates. Statistical significances denoted by asterisks in Figures 1 through
3 are shown as comparison between the respective control (i.e., without genistein,
kaempferol, and quercetin) and genistein, kaempferol, and quercetin A549 cells treated
subgroups. *p < 0.05. Vertical bars in this and other figures denote standard deviation. The
X-axis labels for Figures 1 through 3 are defined as follows: 0 means control cell samples
not treated with genistein, kaempferol, and quercetin; 5, 10, 15, 20, and 25 μM means cell
samples were each treated with the respective dose of genistein, kaempferol, and quercetin
for 24 hours.
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Figure 2.

The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and
quercetin on phospho tensin homolog (PTEN) in breast cancer cell line, BT549, following
incubation at 37 °C and 5% CO2 for 24 hours. For comparison and statistical differences, see
Figure 1.
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Figure 3.

The effects of several doses (0, 5, 10, 15, 20, and 25 μM) each of genistein, kaempferol, and
quercetin on phospho tensin homolog (PTEN) in human embryonic cells, HEK293,
following incubation at 37 °C and 5% CO2 for 24 hours. For comparison and statistical
differences, see Figure 1.
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Figure 4.
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The effects of several doses of genistein (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F1, F2,
and F3) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for
24 hours. Statistical significances denoted by asterisk in Figures 4 through 9 are shown as
comparison between the respective control (i.e., without genistein, kaempferol, or quercetin)
and with genistein, kaempferol, or quercetin PBMCs cells treated subgroups without
oxidative damage.. For comparison and statistical differences, see Figure 1.
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Figure 5.
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The effects of several doses of genistein (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F1, F2,
and F3) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.
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Figure 6.

The effects of several doses of kaempferol (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F4, F5,
and F6) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for
24 hours. For comparison and statistical differences, see Figure 4.
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Figure 7.

The effects of several doses of kaempferol (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F4, F5,
and F6) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.
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Figure 8.

The effects of several doses of quercetin (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F7, F8,
and F9) without oxidative damage in PBMCs following incubation at 37 °C and 5% CO2 for
24 hours. For comparison and statistical differences, see Figure 4.
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Figure 9.

The effects of several doses of quercetin (0, 5, 10, 15, 20, and 25 μM) on lipid peroxides in
peripheral blood mononuclear cells (PBMCs) from three independent donors (i.e., F7, F8,
and F9) with Fe2+ induced oxidative damage in PBMCs following incubation at 37 °C and
5% CO2 for 24 hours. For comparison and statistical differences, see Figure 4.

Author Manuscript
J Am Coll Nutr. Author manuscript; available in PMC 2021 February 01.

